Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
decompression sickness or arterial gas embolism
advanced life support
Initial first-aid treatment should be given according to accepted principles of basic and advanced life support.
Prompt administration of 100% oxygen has been shown to improve clinical outcome.[43]Leitch DR, Green RD. Pulmonary barotrauma in divers and the treatment of cerebral arterial gas embolism. Aviat Space Environ Med. 1986 Oct;57(10):931-8. http://www.ncbi.nlm.nih.gov/pubmed/3778391?tool=bestpractice.com
Isotonic oral fluids can be given in a conscious patient with mild decompression illness. Otherwise, 1-2 litres of intravenous fluids during the first post-injury hour is recommended, followed by an infusion with the goal of normotension and urine output of 0.5 to 1.0 mL/kg/hour.[1]Mitchell SJ, Bennett MH, Moon RE. Decompression sickness and arterial gas embolism. N Engl J Med. 2022 Mar 31;386(13):1254-64. http://www.ncbi.nlm.nih.gov/pubmed/35353963?tool=bestpractice.com
Wet divers are often cold and should be dried, as hypothermia will slow inert gas washout. Conversely, increased body temperature may encourage bubble formation.[45]Mekjavić IB, Kakitsuba N. Effect of peripheral temperature on the formation of venous gas bubbles. Undersea Biomed Res. 1989 Sep;16(5):391-401. http://www.ncbi.nlm.nih.gov/pubmed/2800052?tool=bestpractice.com
To minimise the detrimental effect of bubble expansion with decreased atmospheric pressure at altitude, transport to a suitable facility should ideally be via ground or by aircraft pressurised to sea level.[47]MacDonald RD, O'Donnell C, Allan GM, et al. Interfacility transport of patients with decompression illness: literature review and consensus statement. Prehosp Emerg Care. 2006 Oct-Dec;10(4):482-7. http://www.ncbi.nlm.nih.gov/pubmed/16997779?tool=bestpractice.com In patients with air embolism, horizontal positioning of the patient helps reduce the risk of further embolism or emboli migration while in transit to a hyperbaric chamber.
urgent recompression
Treatment recommended for ALL patients in selected patient group
Patients with decompression sickness should be recompressed in a hyperbaric chamber as soon as is practically possible. Prompt recompression is key. A 95% probability of relief has been demonstrated if treatment is initiated within 30 minutes. This drops to 77% if the delay exceeds 6 hours.[46]Rivera JC. Decompression sickness among divers: an analysis of 935 cases. Mil Med. 1964 Apr;129:314-34. http://www.ncbi.nlm.nih.gov/pubmed/14169233?tool=bestpractice.com In the hyperacute setting, recompression may act to mechanically reduce bubble volume (Boyle’s law) and/or force gas back into solution (Henry’s law). In addition to reduction in bubble volume, hyperbaric oxygen’s modulation of systemic inflammatory response likely also plays a significant role, especially in more delayed presentations.[48]Neuman TS. Arterial gas embolism and decompression sickness. News Physiol Sci. 2002 Apr;17:77-81. http://www.ncbi.nlm.nih.gov/pubmed/11909997?tool=bestpractice.com Empirically derived recompression schedules (or 'treatment tables') have been developed, which vary in their maximum depth (pressure), duration, and the breathing gas mixture used.
In patients with air embolism, treatment follows the principles of decompression illness. Administration of 100% oxygen by close-fitting mask will help dissolve and dissipate emboli, treat hypoxia, reduce cerebral oedema, and limit the acute inflammatory reaction. Due to the risk of occult pneumothorax, femoral central venous lines are preferred to those in jugular or subclavian veins. Any pneumothorax must be drained with a chest tube before recompression, to avoid progression to a tension pneumothorax during hyperbaric exposure. Air in the endotracheal cuffs of intubated patients should be replaced with an equivalent amount of liquid (e.g., saline or distilled water) or monitored through pressure changes by staff to prevent loss of seal or overinflation.[Figure caption and citation for the preceding image starts]: A typical multi-place hyperbaric chamberFrom the collection of Dr Oliver Firth; used with permission [Citation ends].
anticonvulsant
Additional treatment recommended for SOME patients in selected patient group
Cerebral arterial gas embolism can present with generalised seizures, which are treated similarly to seizures from any other cause.
First-line anticonvulsants are intravenous lorazepam, or rectal diazepam if there is no intravenous access. If seizures recur or fail to respond within 30 minutes, either a phenytoin or a phenobarbital infusion may be used.
Doses presented here are for acute repetitive seizures/status epilepticus; maintenance dosing (if required) is beyond the scope of this topic.
Primary options
lorazepam: 4 mg intravenously as a single dose, may repeat in 10-15 minutes according to response, maximum 8 mg/total dose
OR
diazepam rectal: 0.2 mg/kg rectally as a single dose, may repeat once in 4-12 hours according to response
Secondary options
phenytoin: 15-20 mg/kg intravenously as a single dose, may give an additional dose of 10 mg/kg after 20 minutes according to response
OR
phenobarbital: 15-20 mg/kg intravenously as a single dose, may give an additional dose of up to 15 mg/kg after 15 minutes according to response
barotrauma
avoidance of pressure changes
Avoidance of pressure changes until tissue damage has resolved is common to the treatment of all barotraumas.
nasal or oral decongestant
Treatment recommended for ALL patients in selected patient group
Middle-ear barotraumas can be treated with nasal or oral decongestants to reduce the inflammation, although this is seldom warranted.
Pseudoephedrine-containing medications are associated with a risk of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS). These are rare conditions with potentially serious and life-threatening complications. Pseudoephedrine-containing medicines should not be used in patients with severe or uncontrolled hypertension, or those with severe acute or chronic renal disease or failure.[51]European Medicines Agency. Pseudoephedrine-containing medicinal products - referral. Feb 2024 [internet publication]. https://www.ema.europa.eu/en/medicines/human/referrals/pseudoephedrine-containing-medicinal-products
Primary options
ephedrine: (0.25%) 1-2 sprays in each nostril three to four times daily
OR
pseudoephedrine: 60 mg orally (immediate-release) every 4-6 hours when required, maximum 240 mg/day
analgesia
Additional treatment recommended for SOME patients in selected patient group
Analgesics can be administered for pain relief. Simple analgesics such as paracetamol or a non-steroidal anti-inflammatory drug such as diclofenac may be adequate. A short course of opioids (e.g., paracetamol/codeine) may be considered in refractory cases.
Primary options
paracetamol: 500-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day
OR
paracetamol/codeine: 1-2 tablets orally every 4-6 hours when required, maximum 60 mg/dose (codeine) or 4000 mg/day (paracetamol)
OR
diclofenac potassium: 50 mg orally (immediate-release) three times daily when required
conservative measures
Treatment recommended for ALL patients in selected patient group
Conservative measures are bed rest, head elevation, and minimisation of perilymph pressure increases. The patient should avoid coughing, sneezing, equalising, and any physical exertion (e.g., the use of stool softeners is recommended).
analgesia
Additional treatment recommended for SOME patients in selected patient group
Analgesics can be administered for pain relief. Simple analgesics such as paracetamol or a non-steroidal anti-inflammatory drug such as diclofenac may be adequate. A short course of opioids (e.g., paracetamol/codeine) may be considered in refractory cases.
Primary options
paracetamol: 500-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day
OR
paracetamol/codeine: 1-2 tablets orally every 4-6 hours when required, maximum 60 mg/dose (codeine) or 4000 mg/day (paracetamol)
OR
diclofenac potassium: 50 mg orally (immediate-release) three times daily when required
surgical repair
Additional treatment recommended for SOME patients in selected patient group
If symptoms persist or deteriorate, operative intervention is considered. Oval or round window repair prevents further perilymph leakage and may improve vertigo, tinnitus, and hearing.
oxygen therapy or conservative measures
Treatment recommended for ALL patients in selected patient group
Pulmonary tissue damage: 100% oxygen is administered to correct arterial hypoxaemia, avoiding positive pressure ventilation where possible as this may exacerbate lung damage. Haemodynamic support may be required.
Pneumothorax: mild cases may resolve with normobaric 100% oxygen.
Mediastinal emphysema: if asymptomatic, rest and observation may suffice. Mild symptomatic cases may resolve with normobaric 100% oxygen.
recompression ± surgery
Additional treatment recommended for SOME patients in selected patient group
Recompression in a hyperbaric chamber is only very rarely indicated in severe cases of mediastinal emphysema or when air embolism is present.
Myringotomy may be required if patients are unable to equalise their middle-ear spaces voluntarily during recompression treatment.
chest drain or thoracostomy
Additional treatment recommended for SOME patients in selected patient group
In patients with pneumothorax, placement of a chest drain or emergency needle thoracostomy may be required, depending on clinical severity.
nasal or oral decongestant
Treatment recommended for ALL patients in selected patient group
Nasal or oral decongestants are generally used to reduce the inflammation.
Pseudoephedrine-containing medicines are associated with a risk of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS). These are rare conditions with potentially serious and life-threatening complications. Pseudoephedrine-containing medicines should not be used in patients with severe or uncontrolled hypertension, or those with severe acute or chronic renal disease or failure.[51]European Medicines Agency. Pseudoephedrine-containing medicinal products - referral. Feb 2024 [internet publication]. https://www.ema.europa.eu/en/medicines/human/referrals/pseudoephedrine-containing-medicinal-products
Primary options
ephedrine: (0.25%) 1-2 sprays in each nostril three to four times daily
OR
pseudoephedrine: 60 mg orally (immediate-release) every 4-6 hours when required, maximum 240 mg/day
analgesia
Additional treatment recommended for SOME patients in selected patient group
Analgesics can be administered for pain relief. Simple analgesics such as paracetamol or a non-steroidal anti-inflammatory drug such as diclofenac may be adequate. A short course of opioids (e.g., parcetamol/codeine) may be considered in refractory cases.
Primary options
paracetamol: 500-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day
OR
paracetamol/codeine: 1-2 tablets orally every 4-6 hours when required, maximum 60 mg/dose (codeine) or 4000 mg/day (paracetamol)
OR
diclofenac potassium: 50 mg orally (immediate-release) three times daily when required
intranasal corticosteroid
Additional treatment recommended for SOME patients in selected patient group
If the cause of obstruction is mucosal swelling due to allergy or nasal polyps, an intranasal corticosteroid can be added.
Primary options
fluticasone propionate nasal: (50 micrograms/spray) 100 micrograms (2 sprays) in each nostril once daily
OR
beclometasone nasal: (50 micrograms/spray) 50-100 micrograms (1-2 sprays) in each nostril twice daily
endoscopic surgery
Additional treatment recommended for SOME patients in selected patient group
In refractory or recurrent cases, endoscopic exploration or surgery may be needed to improve patency of the ostia or to remove obstructions such as polyps or redundant mucosal folds.
analgesia plus surgical repair
Treatment recommended for ALL patients in selected patient group
Dental barotraumas are treated with analgesics and repair of dental injuries. Dental barotrauma is usually very painful and analgesics are generally required. Simple analgesics such as paracetamol or a non-steroidal anti-inflammatory drug such as diclofenac may be adequate. A short course of opioids (e.g., paracetamol/codeine) may be considered in refractory cases.
Primary options
paracetamol: 500-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day
OR
paracetamol/codeine: 1-2 tablets orally every 4-6 hours when required, maximum 60 mg/dose (codeine) or 4000 mg/day (paracetamol)
OR
diclofenac potassium: 50 mg orally (immediate-release) three times daily when required
surgical repair
Additional treatment recommended for SOME patients in selected patient group
Gastrointestinal barotrauma is rarely severe, but if gastric rupture occurs, stomach contents may enter the peritoneal cavity and emergent surgical repair is imperative.
observation
Treatment recommended for ALL patients in selected patient group
Mask/suit squeeze does not require any treatment, as it resolves spontaneously.
analgesia
Additional treatment recommended for SOME patients in selected patient group
Analgesics can be administered for pain relief. Simple analgesics such as paracetamol or a non-steroidal anti-inflammatory drug such as diclofenac may be adequate. A short course of opioids (e.g., paracetamol/codeine) may be considered in refractory cases.
Primary options
paracetamol: 500-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day
OR
paracetamol/codeine: 1-2 tablets orally every 4-6 hours when required, maximum 60 mg/dose (codeine) or 4000 mg/day (paracetamol)
OR
diclofenac potassium: 50 mg orally (immediate-release) three times daily when required
nitrogen narcosis
ascent
This condition is entirely reversible by reduction of ambient pressure (i.e., ascent to shallow depths).[3]US Navy. US Navy diving manual revision 7 with change A entered - chapter 17: diagnosis and treatment of decompression sickness and arterial gas embolism. Washington, DC: US Navy; 2018. https://www.navsea.navy.mil/Home/SUPSALV/00C3-Diving/Diving-Publications Persistent symptoms after return to ambient pressure should not be attributed to nitrogen narcosis and alternative diagnosis should be sought.
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer